investorscraft@gmail.com

Intrinsic ValueAscom Holding AG (ASCN.SW)

Previous CloseCHF5.35
Intrinsic Value
Upside potential
Previous Close
CHF5.35

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Ascom Holding AG is a Swiss-based provider of healthcare ICT and mobile workflow solutions, operating globally in the medical and enterprise sectors. The company specializes in nurse call systems, clinical workflow software, and mobile communication devices, catering primarily to hospitals, long-term care facilities, and industries like retail and hospitality. Its flagship products, such as teleCARE IP and Telligence, integrate real-time monitoring and response systems, enhancing operational efficiency in healthcare settings. Ascom differentiates itself through a focus on interoperability and workflow orchestration, leveraging its Unite platform to unify disparate systems into a cohesive user experience. The company holds a niche position in the healthcare IT market, competing with larger players by offering tailored, scalable solutions for acute and long-term care environments. Its presence in enterprise sectors further diversifies revenue streams, though healthcare remains its core focus. Ascom’s market position is reinforced by its consultative approach, combining hardware, software, and services to address complex workflow challenges.

Revenue Profitability And Efficiency

Ascom reported revenue of CHF 286.7 million for the period, with net income of CHF 3.7 million, reflecting modest profitability. Diluted EPS stood at CHF 0.10, indicating stable but narrow margins. Operating cash flow of CHF 20 million suggests healthy liquidity generation, though capital expenditures of CHF 4.4 million highlight ongoing investments in product development and infrastructure. The absence of debt strengthens its financial flexibility.

Earnings Power And Capital Efficiency

The company’s earnings power is constrained by its niche market focus, with diluted EPS of CHF 0.10 underscoring limited scalability. However, its debt-free balance sheet and positive operating cash flow demonstrate efficient capital management. The beta of 1.12 indicates moderate market sensitivity, aligning with its stable but growth-dependent profile in healthcare IT.

Balance Sheet And Financial Health

Ascom maintains a robust balance sheet with CHF 18.6 million in cash and no debt, ensuring liquidity for operational needs and strategic initiatives. The lack of leverage reduces financial risk, while consistent operating cash flow supports reinvestment and dividend payments. Its financial health is further underscored by a market capitalization of CHF 118.9 million, reflecting investor confidence in its niche positioning.

Growth Trends And Dividend Policy

Growth is likely driven by demand for digital healthcare solutions, though revenue scalability remains a challenge. The company pays a dividend of CHF 0.10 per share, signaling a commitment to shareholder returns despite modest earnings. Future expansion may hinge on broader adoption of its workflow orchestration platforms and cross-sector diversification.

Valuation And Market Expectations

With a market cap of CHF 118.9 million, Ascom trades at a valuation reflective of its niche market role and steady cash flows. Investors appear to price in moderate growth expectations, balanced by its debt-free structure and dividend yield. The beta of 1.12 suggests alignment with broader market movements.

Strategic Advantages And Outlook

Ascom’s strategic edge lies in its integrated workflow solutions and healthcare specialization, though competition from larger IT providers poses risks. The outlook is cautiously optimistic, with potential growth tied to healthcare digitization trends. Its debt-free status and cash flow stability provide a foundation for incremental innovation and market expansion.

Sources

Company filings, market data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount